This article has been cited by other articles in PMC.
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (637K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
These references are in PubMed. This may not be the complete list of references from this article.
Alexanderson B, Evans DA, Sjöqvist F. Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. Br Med J. 1969 Dec 27;4(5686):764–768.[PMC free article][PubMed]
ANGST J. ANTIDEPRESSIVER EFFEKT UND GENETISCHE FAKTOREN. Arzneimittelforschung. 1964 Jun;14:SUPPL–SUPPL:500.[PubMed]
AZRIN NH. Time-out from positive reinforcement. Science. 1961 Feb 10;133(3450):382–383.[PubMed]
BERNHARD K, BEER H. [Activity of expired carbon dioxide, CNS and other organs after the administration of C14-labelled N-(gamma-dimethyl-aminopropyl)-iminodibenzyl (psychopharmacological drug Tofranil) to rats and dogs]. Helv Physiol Pharmacol Acta. 1962;20:114–121.[PubMed]
Bickel MH, Weder HJ. The total fate of a drug: kinetics of distribution, excretion, and formation of 14 metabolites in rats treated with imipramine. Arch Int Pharmacodyn Ther. 1968 Jun;173(2):433–463.[PubMed]
CARNEY MW, ROTH M, GARSIDE RF. THE DIAGNOSIS OF DEPRESSIVE SYNDROMES AND THE PREDICTION OF E.C.T. RESPONSE. Br J Psychiatry. 1965 Aug;111:659–674.[PubMed]
Edwards G. Comparison of the effect of imipramine and desipramine on some symptoms of depressive illness. Br J Psychiatry. 1965 Sep;111(478):889–897.[PubMed]
GILLETTE JR, DINGELL JV, SULSER F, KUNTZMAN R, BRODIE BB. Isolation from rat brain of a metabolic product, desmethylimipramine, that mediates the antidepressant activity of imipramine (Tofranil). Experientia. 1961 Sep 15;17:417–418.[PubMed]
HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56–62.[PMC free article][PubMed]
Hammer W, Mårtens S, Sjöqvist F. A comparative study of the metabolism of desmethylimipramine, nortriptyline, and oxyphenylbutazone in man. Clin Pharmacol Ther. 1969 Jan-Feb;10(1):44–49.[PubMed]
Hammer W, Sjöqvist F. Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds. Life Sci. 1967 Sep 1;6(17):1895–1903.[PubMed]
HAYDU GG, DHRYMIOTIS A, QUINN GP. Plasma imipramine level in syndromes of depression. Am J Psychiatry. 1962 Dec;119:574–575.[PubMed]
HERRMANN B. QUANTITATIVE METHODEN ZUR UNTERSUCHUNG DES STOFFWECHSELS VON TOFRANIL. Helv Physiol Pharmacol Acta. 1963;21:402–408.[PubMed]
HERRMANN B, PULVER R. [Metabolism of the psychopharmacological agent tofranil]. Arch Int Pharmacodyn Ther. 1960 Jul 1;126:454–469.[PubMed]
Moody JP, Tait AC, Todrick A. Plasma levels of imipramine and desmethylimipramine during therapy. Br J Psychiatry. 1967 Feb;113(495):183–193.[PubMed]
Rose JT, Westhead TT. Treatment of depression. A comparative trial of imipramine and desipramine. Br J Psychiatry. 1967 Jun;113(499):659–665.[PubMed]
SULSER F, WATTS J, BRODIE BB. On the mechanism of antidepressant action of imipraminelike drugs. Ann N Y Acad Sci. 1962 Jan 13;96:279–288.[PubMed]
YATES CM, TODRICK A, TAIT AC. Aspects of the clinical chemistry of desmethylimipramine in man. J Pharm Pharmacol. 1963 Jul;15:432–439.[PubMed]
Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press